Chris Hamby (@ChrisDHamby) header
Chris Hamby (@ChrisDHamby) profile picture

Investigative reporter @NYTimes. Author of Soul Full of Coal Dust, in stores and online now: https://nitter.cf/t.co/BQffThH14M. D.C. resident. Nashville native.

Joined September 2010
Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)Photo by Chris Hamby (@ChrisDHamby)
To understand the at-home ketamine boom, I spoke with 40+ patients. Many called the drug profoundly helpful, but some described addiction and bladder problems -- known risks of recreational use that have been largely downplayed in the medical community. nytimes.com/2023/02/20/us/ke…
5
8
2
22
4,293
Pandemic-era telemedicine rule changes have made it much easier to take the mind-altering drug ketamine at home. Many mental health patients have benefited, but the industry's rapid growth has outpaced evidence of safety. nytimes.com/2023/02/20/us/ke…
1
2
1
3
1,979
Primed by glowing media coverage and aggressive advertising, many patients regard ketamine and its newfound at-home availability as akin to a miracle cure. But there are many unknowns -- and risks. An investigation by @ChrisDHamby @nytimes nytimes.com/2023/02/20/us/ke…
3
5
1
7
26,030
Peruse for yourself the 100,00-plus documents that @PekingMike & I used to tell the story of McKinsey's broader work for opioid manufacturers: industrydocuments.ucsf.edu/o… Our story: nytimes.com/2022/06/29/busin…
2
3
1
13
Chris Hamby retweeted
In addition to helping Purdue Pharma "turbocharge" OxyContin sales while overdoses were surging in America, consulting giant McKinsey simultaneously worked with other drugmakers to boost $$$ of even stronger opioids like Opana. @ChrisDHamby @PekingMike nytimes.com/2022/06/29/busin…
2
10
2
14
EXCLUSIVE: As part of its 2021 settlement with US states, McKinsey pledged to make public documents on its work with opioid makers going back more than a decade. The docs show the firm's advice extended well beyond Purdue Pharma. By @ChrisDHamby and me nytimes.com/2022/06/29/busin…
10
35
9
81
In a hearing today, McKinsey's top executive apologized for the firm's work for opioid manufacturers. Members of Congress called his words hollow and referred to the $86 million McKinsey received from Purdue Pharma as "blood money." w/@PekingMike @waltbogdanich
1
9
17
Op-ed from a retired miner with black lung: Benefits in jeopardy w/out action by Congress. "I am absolutely counting on Manchin to get this done." wvgazettemail.com/opinion/op… I had the privilege of speaking with Arvin for my book. His predicament hasn't dampened his jovial optimism.
2
1
Have a look at some of the documents we drew on to tell the story of McKinsey and its work for both opioid manufacturers and the F.D.A.: industrydocuments.ucsf.edu/d… oversight.house.gov/news/pre…
2
4
For anyone looking for a good read on a timely subject, might I suggest my former @publicintegrity colleague Ronnie Greene's new book Heart of Atlanta: chicagoreviewpress.com/heart… It's the human story behind one of the most underappreciated Supreme Court civil rights cases.
Nice @niemanstory interview with @JimGMorris -- fellow @publicintegrity alumnus, legendary reporter and beard aficionado -- about launching a nonprofit investigative news outlet (@pubhealthwatch) during a pandemic: niemanstoryboard.org/stories…